Can We Approach Zero Relapse in Breast Cancer?

Can We Approach Zero Relapse in Breast Cancer? Eleftherios P. Mamounas Oncologist 2005; 10: 9-17 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in breast cancer and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Discuss the factor most likely to contribute to further decreases in breast cancer mortality. Describe the achievements made in the adjuvant treatment of both node-negative and node-positive breast cancer. Explain the evolving role of targeted therapies and genomics in breast cancer. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Nov. 04, 2005 Most Recent Review: Nov. 04, 2005* Most Recent Update: Nov. 04, 2005 Date Credit Expires: Nov. 04, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.